Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Renal Denervation (RDN) for Heart Failure: A Single-Center, Prospective Cohort Study

NCT07558902 is registered in ClinicalTrials.gov with Shanghai Golden Leaf MedTec Co. Ltd as lead sponsor.

NCT NCT07558902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07558902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Renal Denervation (RDN) for Heart Failure: A Single-Center, Prospective Cohort Study
Lead sponsor
Shanghai Golden Leaf MedTec Co. Ltd
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 10, 2026
Completion date
September 13, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure